Jutfelt, 2011 - Google Patents
Barrier function of the gutJutfelt, 2011
View PDF- Document ID
- 12681205719909577647
- Author
- Jutfelt F
- Publication year
- Publication venue
- Encyclopedia of fish physiology: from genome to environment
External Links
Snippet
The gastrointestinal lumen contains microorganisms, some that are pathogenic, and toxins that would kill the fish if allowed to enter the circulation. What the fish needs, therefore, is a protective barrier to keep unwanted agents out, yet minimize the interference with other …
- 230000004888 barrier function 0 title abstract description 31
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
- A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jutfelt | Barrier function of the gut | |
Dawood et al. | Antiparasitic and antibacterial functionality of essential oils: An alternative approach for sustainable aquaculture | |
Paray et al. | Yucca schidigera usage for healthy aquatic animals: Potential roles for sustainability | |
Kong et al. | Effect of Bacillus subtilis on Aeromonas hydrophila-induced intestinal mucosal barrier function damage and inflammation in grass carp (Ctenopharyngodon idella) | |
Cámara-Ruiz et al. | Probiotic Shewanella putrefaciens (SpPdp11) as a fish health modulator: a review | |
Adel et al. | Dietary peppermint (Mentha piperita) extracts promote growth performance and increase the main humoral immune parameters (both at mucosal and systemic level) of Caspian brown trout (Salmo trutta caspius Kessler, 1877) | |
Nimalan et al. | Mucosal barrier status in Atlantic salmon fed marine or plant-based diets supplemented with probiotics | |
Pereira et al. | Use of probiotic bacteria and bacteriocins as an alternative to antibiotics in aquaculture | |
Wang et al. | The toxic effects of microcystin-LR on mouse lungs and alveolar type II epithelial cells | |
Wan et al. | Amelioration of enterotoxigenic Escherichia coli-induced intestinal barrier disruption by low-molecular-weight chitosan in weaned pigs is related to suppressed intestinal inflammation and apoptosis | |
Khater et al. | Therapeutic potential of quercetin loaded nanoparticles: Novel insights in alleviating colitis in an experimental DSS induced colitis model | |
Oliveira et al. | Lactobacillus reuteri DSM 17938 protects against gastric damage induced by ethanol administration in mice: role of TRPV1/substance P axis | |
di Vito et al. | A multi-strain probiotic formulation improves intestinal barrier function by the modulation of tight and adherent junction proteins | |
Xu et al. | Immunomodulatory effects of chicken egg yolk antibodies (IgY) against experimental Shewanella marisflavi AP629 infections in sea cucumbers (Apostichopus japonicus) | |
Eckel et al. | Bacterial endotoxins and their role in periparturient diseases of dairy cows: mucosal vaccine perspectives | |
Dangeubun et al. | Hematology of Vibrio alginolyticus-infected humpback grouper Cromileptes altivelis, under treatment of Alstonia acuminata shoot extract | |
Jasim et al. | Probiotic effects of the fungi, Aspergillus niger on growth, immunity, haematology, intestine fungal load and digestive enzymes of the common carp, Cyprinus carpio | |
Wen et al. | Protective effect of low molecular weight seleno-aminopolysaccharide on the intestinal mucosal oxidative damage | |
Zheng et al. | Lactobacillus casei Zhang counteracts blood-milk barrier disruption and moderates the inflammatory response in Escherichia coli-induced mastitis | |
De Leo et al. | Polymer encapsulated liposomes for oral co-delivery of curcumin and hydroxytyrosol | |
Yu et al. | Trans-anethole alleviates subclinical necro-haemorrhagic enteritis-induced intestinal barrier dysfunction and intestinal inflammation in broilers | |
Saleh et al. | Therapeutic intervention with dietary chitosan nanoparticles alleviates fish pathological and molecular systemic inflammatory responses against infections | |
Zhou et al. | Protective effects of Lactobacillus plantarum Lac16 on Clostridium perfringens infection-associated injury in IPEC-J2 cells | |
Sîrbu et al. | Effects of dietary supplementation with probiotics and prebiotics on growth, physiological condition, and resistance to pathogens challenge in Nile tilapia (Oreochromis niloticus) | |
González‐Silvera et al. | Immune defence mechanisms presented in liver homogenates and bile of gilthead seabream (Sparus aurata) |